Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001596919 | SCV002242763 | pathogenic | not provided | 2023-11-19 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 219 of the ALPL protein (p.Met219Ile). This variant is present in population databases (rs776117933, gnomAD 0.004%). This missense change has been observed in individuals with hypophosphatasia (Invitae). ClinVar contains an entry for this variant (Variation ID: 1224381). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ALPL protein function with a positive predictive value of 95%. This variant disrupts the p.Met219 amino acid residue in ALPL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 24022022; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003333168 | SCV004041334 | likely pathogenic | Hypophosphatasia | 2023-06-23 | criteria provided, single submitter | clinical testing | |
JKU Lab, |
RCV003333168 | SCV004175719 | likely pathogenic | Hypophosphatasia | 2023-12-05 | criteria provided, single submitter | clinical testing | GnomAD low freq 0.0015908% (4). The functional test results and ACMG criteria applied can be looked up in the ALPL gene variant database. https://alplmutationdatabase.jku.at/ |
Baylor Genetics | RCV003470872 | SCV004195097 | likely pathogenic | Adult hypophosphatasia | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001596919 | SCV001832446 | uncertain significance | not provided | 2019-11-30 | flagged submission | clinical testing |